Annexon Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- Tech drags S&P 500, Nasdaq lower as more Iran sanctions, Nvidia earnings loom
- Oil slips ahead of US announcement of new sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Tech drags S&P 500, Nasdaq lower as more Iran sanctions, Nvidia earnings loom
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
- Funds sell $44bn in semiconductors on AI concerns
Annexon Biosciences (ANNX) PT Raised to $14 at Wells Fargo
June 5, 2024 5:54 AM EDTWells Fargo analyst Derek Archila raised the price target on Annexon Biosciences (NASDAQ: ANNX) to $14.00 (from $10.00) while maintaining a Overweight rating.
The analyst comments "ANX005 only had to win on one dose. Let's be clear: the study was powered... More
